Metabolomic and Transcriptomic Profiling Identified Significant Genes in Thymic Epithelial Tumor
Thymomas and thymic carcinomas are malignant thymic epithelial tumors (TETs) with poor outcomes if non-resectable. However, the tumorigenesis, especially the metabolic mechanisms involved, is poorly studied. Untargeted metabolomics analysis was utilized to screen for differential metabolic profiles...
Main Authors: | Enyu Tang, Yang Zhou, Siyang Liu, Zhiming Zhang, Rixin Zhang, Dejing Huang, Tong Gao, Tianze Zhang, Guangquan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/6/567 |
Similar Items
-
Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas
by: Guanyun Wang, et al.
Published: (2022-08-01) -
Current Treatment Approaches for Thymic Epithelial Tumors
by: Alfredo Tartarone, et al.
Published: (2023-05-01) -
Qualitative Changes in Cortical Thymic Epithelial Cells Drive Postpartum Thymic Regeneration
by: Maude Dumont-Lagacé, et al.
Published: (2020-01-01) -
Thymic Epithelial Tumors: An Evolving Field
by: Elisabetta Kuhn, et al.
Published: (2023-01-01) -
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
by: Chunwei Xu, et al.
Published: (2023-04-01)